Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.

Mansoor Raza Mirza, Gitte-Betina Nyvang, Bente Lund, Rene dePont Christensen, Theresa Louise Werner, Susanne Malander, Line Bjørge, Michael J. Birrer, Maarit Anttila, Gabriel Lindahl, Sakari Hietanen, Maria Dimoula, Ulla Peen, Kristine Madsen, Anja Knudsen, Synnove Staff, Nicole Buchner Vinum, Maj Kamille Kjeldsen, Elisabeth Avall-Lundqvist, Johanna Unelma Maenpaa

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind38
Udgave nummer15, suppl.
Sider (fra-til)6012-6012
Antal sider1
ISSN0732-183X
DOI
StatusUdgivet - 2020
Begivenhed2020 ASCO Annual Meeting -
Varighed: 29 maj 202031 maj 2020

Konference

Konference2020 ASCO Annual Meeting
Periode29/05/202031/05/2020

Citationsformater